Skip to main content
Year archive

NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD — 2025 filings

All 52 regulatory filings released by NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD (NSB) in 2025, sourced directly from the official regulator.

52 Filings
2025 Period
2025 filings (52)
Filing Released Lang
Investor Webinar Update 2 pages 248.6KB
Investor Presentation
2025-11-11 English
Results of Annual General Meeting 4 pages 189.3KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-11 English
Fourth Patient Commences StemSmart MSC Treatment 4 pages 281.9KB
Regulatory Filings
2025-11-10 English
Clinical & Scientific Advisory Board Appointed 3 pages 268.8KB
Board/Management Information
2025-11-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 564.7KB
Interim / Quarterly Report Q1 2026
2025-10-29 English
AusBiotech Presentation 12 pages 1.9MB
Investor Presentation
2025-10-20 English
First Patients Approved for Special Access Program 4 pages 278.5KB
Regulatory Filings
2025-10-06 English
Notice of Meeting & Proxy Form 36 pages 696.9KB
AGM Information
2025-10-01 English
Letter to Shareholders & Proxy Form 3 pages 194.5KB
AGM Information
2025-10-01 English
Ceasing to be a substantial holder 2 pages 694.6KB
Major Shareholding Notification
2025-09-18 English
Notification regarding unquoted securities - NSB 8 pages 28.5KB
Share Issue/Capital Change
2025-09-15 English
Date of AGM & Closing Date for Director Nominations 1
AGM Information
2025-09-15 English
2025 Annual Report & Appendix 4E 70 pages 2.1MB
Annual Report FY 2025
2025-08-27 English
Appendix 4G & Corporate Governance Statement 29 pages 629.3KB
Regulatory Filings
2025-08-27 English
Previous StemSmart Studies Support Renal Transplantation 5 pages 365.4KB
Capital/Financing Update
2025-08-26 English
Presentation - TechKnow Invest Roadshow Conference 16 pages 749.4KB
Investor Presentation
2025-08-18 English
NeuroScientific Partners with Leading Biologic Manufacturer 2 pages 280.7KB
Regulatory Filings
2025-07-30 English
Change in substantial holding 2 pages 154.2KB
Regulatory Filings
2025-07-29 English
Experienced Cell Therapy Executive Appointed CEO 3 pages 482.9KB
Board/Management Information
2025-07-27 English
Dr Catherine Cole Appointed as Chief Medical Officer 2 pages 379.0KB
Board/Management Information
2025-07-24 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 1.4MB
Interim / Quarterly Report Q4 2025
2025-07-22 English
Becoming a substantial holder 2 pages 90.1KB
Regulatory Filings
2025-07-09 English
Change in substantial holding 2 pages 86.5KB
Regulatory Filings
2025-07-03 English
Change of Director's Interest Notice (AU) 3 pages 418.7KB
Director's Dealing
2025-06-30 English
Breakthrough Stem Cell Tech Acquired-StemSmart Presentation 21 pages 1.0MB
Investor Presentation
2025-06-29 English
Application for quotation of securities - NSB 6 pages 18.3KB
Share Issue/Capital Change
2025-06-26 English
Application for quotation of securities - NSB 6 pages 18.5KB
Share Issue/Capital Change
2025-06-26 English
Application for quotation of securities - NSB 6 pages 18.4KB
Share Issue/Capital Change
2025-06-26 English
Notification regarding unquoted securities - NSB 6 pages 20.1KB
Share Issue/Capital Change
2025-06-26 English
Notification regarding unquoted securities - NSB 6 pages 20.1KB
Share Issue/Capital Change
2025-06-26 English
Section 708A Notice 1 page 629.8KB
Capital/Financing Update
2025-06-26 English
Final Director's Interest Notice x2 4 pages 956.2KB
Director's Dealing
2025-06-26 English
Change of Director's Interest Notice x2 6 pages 844.2KB
Director's Dealing
2025-06-26 English
Initial Director's Interest Notice x2 4 pages 948.3KB
Director's Dealing
2025-06-26 English
StemSmart Acquisition Complete 3 pages 542.9KB
M&A Activity
2025-06-26 English
Results of General Meeting 3 pages 487.7KB
Declaration of Voting Results & Voting Rights Announcements
2025-06-22 English
Previous StemSmart Studies Demonstrate Clinical Response 8 pages 758.7KB
Regulatory Filings
2025-06-18 English
Notification of cessation of securities - NSB 4 pages 14.7KB
Share Issue/Capital Change
2025-06-17 English
Proposed issue of securities - NSB 5 pages 18.9KB
Capital/Financing Update
2025-05-25 English
Special Access Program Set to Commence 2 pages 528.7KB
Capital/Financing Update
2025-05-22 English
Notice of General Meeting & Proxy Form 44 pages 799.9KB
Proxy Solicitation & Information Statement
2025-05-22 English
Letter to Shareholders & Proxy Form 3 pages 516.0KB
Proxy Solicitation & Information Statement
2025-05-22 English
Change of Director's Interest Notice 4 pages 1.2MB
Director's Dealing
2025-05-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 1.4MB
Interim / Quarterly Report Q3 2025
2025-04-23 English
NeuroScientific to Acquire Leading Stem Cell Technology 11 pages 721.5KB
Capital/Financing Update
2025-04-15 English
Proposed issue of securities - NSB 6 pages 21.3KB
Capital/Financing Update
2025-04-15 English
Proposed issue of securities - NSB 6 pages 22.2KB
Share Issue/Capital Change
2025-04-15 English
Trading Halt 2 pages 949.5KB
Regulatory Filings
2025-04-13 English
Half Yearly Report and Accounts 22 pages 3.7MB
Interim / Quarterly Report H1 2025
2025-02-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.4MB
Interim / Quarterly Report Q4 2024
2025-01-29 English
Change of Registered Office Address 1 page 510.6KB
Regulatory Filings
2025-01-23 English
Notification of cessation of securities - NSB 4 pages 14.7KB
Regulatory Filings
2025-01-21 English